Annual CAPEX
$6.38 M
-$4.00 M-38.56%
31 December 2023
Summary:
BioLife Solutions annual capital expenditures is currently $6.38 million, with the most recent change of -$4.00 million (-38.56%) on 31 December 2023. During the last 3 years, it has risen by +$1.75 million (+37.73%). BLFS annual CAPEX is now -38.56% below its all-time high of $10.38 million, reached on 31 December 2022.BLFS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$1.11 M
+$119.00 K+11.96%
30 September 2024
Summary:
BioLife Solutions quarterly capital expenditures is currently $1.11 million, with the most recent change of +$119.00 thousand (+11.96%) on 30 September 2024. Over the past year, it has dropped by -$382.00 thousand (-25.53%). BLFS quarterly CAPEX is now -74.96% below its all-time high of $4.45 million, reached on 31 December 2022.BLFS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$3.45 M
-$382.00 K-9.98%
30 September 2024
Summary:
BioLife Solutions TTM capital expenditures is currently $3.45 million, with the most recent change of -$382.00 thousand (-9.98%) on 30 September 2024. Over the past year, it has dropped by -$6.40 million (-65.01%). BLFS TTM CAPEX is now -71.81% below its all-time high of $12.22 million, reached on 31 March 2023.BLFS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLFS CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -38.6% | -25.5% | -65.0% |
3 y3 years | +37.7% | -53.8% | -68.9% |
5 y5 years | +1176.2% | +1137.8% | +566.5% |
BLFS CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -38.6% | +37.7% | -75.0% | +212.9% | -71.8% | +0.1% |
5 y | 5 years | -38.6% | +1176.2% | -75.0% | +1137.8% | -71.8% | +566.5% |
alltime | all time | -38.6% | >+9999.0% | -75.0% | +1214.0% | -71.8% | >+9999.0% |
BioLife Solutions CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $1.11 M(+12.0%) | $3.45 M(-10.0%) |
June 2024 | - | $995.00 K(+179.5%) | $3.83 M(+11.2%) |
Mar 2024 | - | $356.00 K(-63.7%) | $3.44 M(-46.1%) |
Dec 2023 | $6.38 M(-38.6%) | $981.00 K(-34.4%) | $6.38 M(-35.2%) |
Sept 2023 | - | $1.50 M(+145.6%) | $9.85 M(-8.8%) |
June 2023 | - | $609.00 K(-81.5%) | $10.80 M(-11.7%) |
Mar 2023 | - | $3.29 M(-25.9%) | $12.22 M(+17.7%) |
Dec 2022 | $10.38 M(+23.9%) | $4.45 M(+81.8%) | $10.38 M(+38.4%) |
Sept 2022 | - | $2.45 M(+20.2%) | $7.50 M(+0.5%) |
June 2022 | - | $2.04 M(+39.8%) | $7.47 M(+0.3%) |
Mar 2022 | - | $1.46 M(-7.0%) | $7.45 M(-11.2%) |
Dec 2021 | $8.38 M(+81.0%) | $1.57 M(-35.1%) | $8.38 M(-24.3%) |
Sept 2021 | - | $2.41 M(+19.7%) | $11.08 M(+26.1%) |
June 2021 | - | $2.02 M(-15.8%) | $8.79 M(+27.8%) |
Mar 2021 | - | $2.39 M(-43.9%) | $6.88 M(+48.5%) |
Dec 2020 | $4.63 M(+586.4%) | $4.26 M(+3482.4%) | $4.63 M(+572.4%) |
Sept 2020 | - | $119.00 K(+13.3%) | $689.00 K(+4.4%) |
June 2020 | - | $105.00 K(-28.1%) | $660.00 K(-19.6%) |
Mar 2020 | - | $146.00 K(-54.2%) | $821.00 K(+21.6%) |
Dec 2019 | $675.00 K(+35.0%) | $319.00 K(+254.4%) | $675.00 K(+30.6%) |
Sept 2019 | - | $90.00 K(-66.2%) | $517.00 K(-26.7%) |
June 2019 | - | $266.00 K(+65.2%) | $705.00 K(+41.0%) |
Dec 2018 | $500.00 K(+247.2%) | $161.00 K(-42.1%) | $500.00 K(+27.7%) |
Sept 2018 | - | $278.00 K(+1290.0%) | $391.60 K(+208.6%) |
June 2018 | - | $20.00 K(-51.2%) | $126.90 K(-14.2%) |
Mar 2018 | - | $41.00 K(-22.1%) | $147.90 K(+2.6%) |
Dec 2017 | $144.00 K(-88.5%) | $52.60 K(+295.5%) | $144.10 K(-60.1%) |
Sept 2017 | - | $13.30 K(-67.6%) | $361.10 K(-33.3%) |
June 2017 | - | $41.00 K(+10.2%) | $541.00 K(-24.3%) |
Mar 2017 | - | $37.20 K(-86.2%) | $714.90 K(-43.1%) |
Dec 2016 | $1.26 M(-11.3%) | $269.60 K(+39.5%) | $1.26 M(-10.6%) |
Sept 2016 | - | $193.20 K(-10.1%) | $1.41 M(-14.4%) |
June 2016 | - | $214.90 K(-62.9%) | $1.64 M(-16.0%) |
Mar 2016 | - | $579.50 K(+38.4%) | $1.96 M(+38.0%) |
Dec 2015 | $1.42 M(+140.4%) | $418.80 K(-2.5%) | $1.42 M(+5.7%) |
Sept 2015 | - | $429.40 K(-18.7%) | $1.34 M(+26.4%) |
June 2015 | - | $528.40 K(+1185.6%) | $1.06 M(+73.4%) |
Mar 2015 | - | $41.10 K(-88.0%) | $612.00 K(+3.8%) |
Dec 2014 | $589.70 K(+149.1%) | $342.50 K(+129.1%) | $589.70 K(+137.0%) |
Sept 2014 | - | $149.50 K(+89.5%) | $248.80 K(+128.9%) |
June 2014 | - | $78.90 K(+319.7%) | $108.70 K(-50.9%) |
Mar 2014 | - | $18.80 K(+1075.0%) | $221.60 K(-6.4%) |
Dec 2013 | $236.70 K(-79.4%) | $1600.00(-83.0%) | $236.70 K(+10.1%) |
Sept 2013 | - | $9400.00(-95.1%) | $215.00 K(-39.3%) |
June 2013 | - | $191.80 K(+465.8%) | $354.20 K(-68.9%) |
Mar 2013 | - | $33.90 K(-268.7%) | $1.14 M(-1.2%) |
Dec 2012 | $1.15 M(+1131.8%) | -$20.10 K(-113.5%) | $1.15 M(-4.7%) |
Sept 2012 | - | $148.60 K(-84.8%) | $1.21 M(+12.5%) |
June 2012 | - | $976.00 K(+1967.8%) | $1.07 M(+743.3%) |
Mar 2012 | - | $47.20 K(+30.4%) | $127.30 K(+36.0%) |
Dec 2011 | $93.50 K(+229.2%) | $36.20 K(+156.7%) | $93.60 K(+35.5%) |
Sept 2011 | - | $14.10 K(-52.7%) | $69.10 K(+19.1%) |
June 2011 | - | $29.80 K(+120.7%) | $58.00 K(+78.5%) |
Mar 2011 | - | $13.50 K(+15.4%) | $32.50 K(+14.4%) |
Dec 2010 | $28.40 K(-92.4%) | $11.70 K(+290.0%) | $28.40 K(+62.3%) |
Sept 2010 | - | $3000.00(-30.2%) | $17.50 K(+1.2%) |
June 2010 | - | $4300.00(-54.3%) | $17.30 K(-86.1%) |
Mar 2010 | - | $9400.00(+1075.0%) | $124.30 K(-66.7%) |
Dec 2009 | $373.50 K | $800.00(-71.4%) | $373.60 K(-0.9%) |
Sept 2009 | - | $2800.00(-97.5%) | $377.10 K(-8.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2009 | - | $111.30 K(-57.0%) | $410.00 K(+36.8%) |
Mar 2009 | - | $258.70 K(+5916.3%) | $299.80 K(+540.6%) |
Dec 2008 | $46.70 K(-55.7%) | $4300.00(-88.0%) | $46.80 K(-22.5%) |
Sept 2008 | - | $35.70 K(+3145.5%) | $60.40 K(+18.9%) |
June 2008 | - | $1100.00(-80.7%) | $50.80 K(-13.2%) |
Mar 2008 | - | $5700.00(-68.2%) | $58.50 K(-44.5%) |
Dec 2007 | $105.50 K(+196.3%) | $17.90 K(-31.4%) | $105.50 K(+7.0%) |
Sept 2007 | - | $26.10 K(+196.6%) | $98.60 K(+22.9%) |
June 2007 | - | $8800.00(-83.3%) | $80.20 K(-5.0%) |
Mar 2007 | - | $52.70 K(+379.1%) | $84.40 K(+137.7%) |
Dec 2006 | $35.60 K(+135.8%) | $11.00 K(+42.9%) | $35.50 K(+31.5%) |
Sept 2006 | - | $7700.00(-40.8%) | $27.00 K(+39.9%) |
June 2006 | - | $13.00 K(+242.1%) | $19.30 K(+2.1%) |
Mar 2006 | - | $3800.00(+52.0%) | $18.90 K(+25.2%) |
Dec 2005 | $15.10 K(-77.1%) | $2500.00(>+9900.0%) | $15.10 K(-9.0%) |
Sept 2005 | - | $0.00(-100.0%) | $16.60 K(0.0%) |
June 2005 | - | $12.60 K(+215.0%) | $16.60 K(-74.8%) |
Dec 2004 | $65.80 K(+487.5%) | $4000.00(>+9900.0%) | $65.80 K(-9.9%) |
Sept 2004 | - | $0.00(-100.0%) | $73.00 K(0.0%) |
June 2004 | - | $11.50 K(-77.1%) | $73.00 K(-496.7%) |
Mar 2004 | - | $50.30 K(+349.1%) | -$18.40 K(-264.3%) |
Dec 2003 | $11.20 K(-87.2%) | $11.20 K(-114.0%) | $11.20 K(-660.0%) |
June 2003 | - | -$79.90 K(-200.0%) | -$2000.00(-101.9%) |
Mar 2003 | - | $79.90 K(-4095.0%) | $104.60 K(+19.7%) |
Dec 2002 | $87.40 K(-68.7%) | -$2000.00(<-9900.0%) | $87.40 K(-24.7%) |
Sept 2002 | - | $0.00(-100.0%) | $116.00 K(-42.3%) |
June 2002 | - | $26.70 K(-57.4%) | $200.90 K(-36.8%) |
Mar 2002 | - | $62.70 K(+135.7%) | $317.80 K(+13.8%) |
Dec 2001 | $279.30 K(+50.4%) | $26.60 K(-68.7%) | $279.30 K(+3.7%) |
Sept 2001 | - | $84.90 K(-40.9%) | $269.30 K(-19.0%) |
June 2001 | - | $143.60 K(+493.4%) | $332.40 K(+58.3%) |
Mar 2001 | - | $24.20 K(+45.8%) | $210.00 K(+13.0%) |
Dec 2000 | $185.70 K(-25.6%) | $16.60 K(-88.8%) | $185.80 K(+9.8%) |
Sept 2000 | - | $148.00 K(+598.1%) | $169.20 K(+698.1%) |
June 2000 | - | $21.20 K(-57.3%) | $21.20 K(-91.5%) |
Dec 1998 | $249.60 K(-29.7%) | $49.60 K(>+9900.0%) | $249.60 K(-2.2%) |
Sept 1998 | - | $0.00(0.0%) | $255.30 K(-43.9%) |
June 1998 | - | $0.00(-100.0%) | $455.30 K(0.0%) |
Mar 1998 | - | $200.00 K(+261.7%) | $455.30 K(+28.1%) |
Dec 1997 | $355.30 K(+474.0%) | $55.30 K(-72.4%) | $355.30 K(+18.4%) |
Sept 1997 | - | $200.00 K(>+9900.0%) | $300.00 K(+50.0%) |
June 1997 | - | $0.00(-100.0%) | $200.00 K(+24.7%) |
Mar 1997 | - | $100.00 K(0.0%) | $160.40 K(0.0%) |
Dec 1996 | $61.90 K(+2.5%) | - | - |
Sept 1996 | - | $100.00 K(-352.5%) | $160.40 K(+165.6%) |
June 1996 | - | -$39.60 K(-139.6%) | $60.40 K(-39.6%) |
June 1996 | $60.40 K(-81.0%) | - | - |
Mar 1996 | - | $100.00 K(0.0%) | $100.00 K(-50.0%) |
June 1995 | $317.20 K(+58.6%) | - | - |
Sept 1994 | - | $100.00 K(-200.0%) | $200.00 K(0.0%) |
June 1994 | $200.00 K(-77.8%) | -$100.00 K(-200.0%) | $200.00 K(-50.0%) |
Mar 1994 | - | $100.00 K(0.0%) | $400.00 K(-33.3%) |
Dec 1993 | - | $100.00 K(0.0%) | $600.00 K(-25.0%) |
Sept 1993 | - | $100.00 K(0.0%) | $800.00 K(-11.1%) |
June 1993 | $900.00 K(+125.0%) | $100.00 K(-66.7%) | $900.00 K(+12.5%) |
Mar 1993 | - | $300.00 K(0.0%) | $800.00 K(+60.0%) |
Dec 1992 | - | $300.00 K(+50.0%) | $500.00 K(+150.0%) |
Sept 1992 | - | $200.00 K | $200.00 K |
June 1992 | $400.00 K(+300.0%) | - | - |
June 1991 | $100.00 K | - | - |
FAQ
- What is BioLife Solutions annual capital expenditures?
- What is the all time high annual CAPEX for BioLife Solutions?
- What is BioLife Solutions annual CAPEX year-on-year change?
- What is BioLife Solutions quarterly capital expenditures?
- What is the all time high quarterly CAPEX for BioLife Solutions?
- What is BioLife Solutions quarterly CAPEX year-on-year change?
- What is BioLife Solutions TTM capital expenditures?
- What is the all time high TTM CAPEX for BioLife Solutions?
- What is BioLife Solutions TTM CAPEX year-on-year change?
What is BioLife Solutions annual capital expenditures?
The current annual CAPEX of BLFS is $6.38 M
What is the all time high annual CAPEX for BioLife Solutions?
BioLife Solutions all-time high annual capital expenditures is $10.38 M
What is BioLife Solutions annual CAPEX year-on-year change?
Over the past year, BLFS annual capital expenditures has changed by -$4.00 M (-38.56%)
What is BioLife Solutions quarterly capital expenditures?
The current quarterly CAPEX of BLFS is $1.11 M
What is the all time high quarterly CAPEX for BioLife Solutions?
BioLife Solutions all-time high quarterly capital expenditures is $4.45 M
What is BioLife Solutions quarterly CAPEX year-on-year change?
Over the past year, BLFS quarterly capital expenditures has changed by -$382.00 K (-25.53%)
What is BioLife Solutions TTM capital expenditures?
The current TTM CAPEX of BLFS is $3.45 M
What is the all time high TTM CAPEX for BioLife Solutions?
BioLife Solutions all-time high TTM capital expenditures is $12.22 M
What is BioLife Solutions TTM CAPEX year-on-year change?
Over the past year, BLFS TTM capital expenditures has changed by -$6.40 M (-65.01%)